Seminar: Exploring regulatory decision-making in healthcare
Why and when are some stakeholders more salient than others?
The Centre for Health Economics at Monash Business School invites you to the research webinar 'Exploring regulatory decision-making in healthcare: Why and when are some stakeholders more salient than others?' presented by Dr Katharina Blankart from CINCH Essen.
Understanding different stakeholders' roles in processes of regulatory decision-making is of great relevance from the perspectives of business, regulators and society. In this paper, we seek to explain why, when, and which stakeholders are salient in regulatory decision-making. To do so, we build a conceptual framework that expands Mitchell, Agle, and Wood's theory of stakeholder salience to include a dimension of case specific context urgency by using concepts grounded in resource dependence and social movement theory. In a mixed-methods approach, we use this framework and qualitative analysis of expert interviews to develop hypotheses on different stakeholders' salience in regulatory decision-making, and on moderating effects of context urgency on these stakeholders' salience. Subsequently, we empirically test our hypotheses using structural equation modeling. Results of analyzing outcomes of health technology assessments of pharmaceuticals in Germany between 2011 and 2015, show that the theory of stakeholder salience can be used to explain different stakeholders' salience in regulatory decision-making. While the inclusion of case-specific measures of context urgency further contributes to the understanding of regulatory decision-making, we did not find moderating effects on stakeholder-regulatory agency relationships, which raises the question of what makes any context urgent enough for a regulatory agency to react to it. Involvement of stakeholders, however, were relevant mediators of the relationship between the initial assessment by a peer-agency and the regulatory decision.
Speaker
Katharina Blankart is an assistant professor in empirical health economics at the Faculty of Business Administration and Economics of University of Duisburg-Essen, a full member of the health economics research center CINCH and head of the junior research group “Empirical Analysis of Health Care Markets (EACH)”. Blankart‘s research covers innovation management, regulatory science and analysis of health care system performance. Her research projects address market access and diffusion of health technologies, valued-based decision-making by health systems and providers, and the impacts of cost-efficiency measures on utilization. She is particularly interested in studying pharmaceutical markets and ambulatory care settings. Her projects use econometric methods that are informed by administrative data, document analyses and surveys. She is the recipient of the 2013 research award of the Society for Health Policy and Law to study health care systems. Katharina Blankart received her degrees in economics and business research from Ludwig-Maximilians-Universität München (LMU). She holds a PhD in business administration with a focus on health economics from (LMU). She was head of the junior research group on pharmacoeconomics at Hamburg Center for Health Economics (HCHE), University of Hamburg between 2012 and 2016. In 2015/2016, she collaborated with Columbia Business School, New York, USA as visiting researcher.
CHE seminar series
At the Centre for Health Economics, we are working on running as many of our seminars as possible online while COVID-19 remains an obstacle to getting together. As we will be working with experts and colleagues in other parts of the world there will be some movement in the times and days that seminars run to take into account different time zones and availabilities. If you would like to be on our seminar email list, please be directly in contact by email to shannon.stanwell@monash.edu.
Hope to see you there!
Event Details
- Date:
- 11 November 2020 at 5:00 pm – 6:00 pm
- Venue:
- This seminar will take place via Zoom - please email shannon.stanwell@monash.edu to register
- Categories:
- Health Economics
Description
Why and when are some stakeholders more salient than others?
The Centre for Health Economics at Monash Business School invites you to the research webinar 'Exploring regulatory decision-making in healthcare: Why and when are some stakeholders more salient than others?' presented by Dr Katharina Blankart from CINCH Essen.
Understanding different stakeholders' roles in processes of regulatory decision-making is of great relevance from the perspectives of business, regulators and society. In this paper, we seek to explain why, when, and which stakeholders are salient in regulatory decision-making. To do so, we build a conceptual framework that expands Mitchell, Agle, and Wood's theory of stakeholder salience to include a dimension of case specific context urgency by using concepts grounded in resource dependence and social movement theory. In a mixed-methods approach, we use this framework and qualitative analysis of expert interviews to develop hypotheses on different stakeholders' salience in regulatory decision-making, and on moderating effects of context urgency on these stakeholders' salience. Subsequently, we empirically test our hypotheses using structural equation modeling. Results of analyzing outcomes of health technology assessments of pharmaceuticals in Germany between 2011 and 2015, show that the theory of stakeholder salience can be used to explain different stakeholders' salience in regulatory decision-making. While the inclusion of case-specific measures of context urgency further contributes to the understanding of regulatory decision-making, we did not find moderating effects on stakeholder-regulatory agency relationships, which raises the question of what makes any context urgent enough for a regulatory agency to react to it. Involvement of stakeholders, however, were relevant mediators of the relationship between the initial assessment by a peer-agency and the regulatory decision.
Speaker
Katharina Blankart is an assistant professor in empirical health economics at the Faculty of Business Administration and Economics of University of Duisburg-Essen, a full member of the health economics research center CINCH and head of the junior research group “Empirical Analysis of Health Care Markets (EACH)”. Blankart‘s research covers innovation management, regulatory science and analysis of health care system performance. Her research projects address market access and diffusion of health technologies, valued-based decision-making by health systems and providers, and the impacts of cost-efficiency measures on utilization. She is particularly interested in studying pharmaceutical markets and ambulatory care settings. Her projects use econometric methods that are informed by administrative data, document analyses and surveys. She is the recipient of the 2013 research award of the Society for Health Policy and Law to study health care systems. Katharina Blankart received her degrees in economics and business research from Ludwig-Maximilians-Universität München (LMU). She holds a PhD in business administration with a focus on health economics from (LMU). She was head of the junior research group on pharmacoeconomics at Hamburg Center for Health Economics (HCHE), University of Hamburg between 2012 and 2016. In 2015/2016, she collaborated with Columbia Business School, New York, USA as visiting researcher.
CHE seminar series
At the Centre for Health Economics, we are working on running as many of our seminars as possible online while COVID-19 remains an obstacle to getting together. As we will be working with experts and colleagues in other parts of the world there will be some movement in the times and days that seminars run to take into account different time zones and availabilities. If you would like to be on our seminar email list, please be directly in contact by email to shannon.stanwell@monash.edu.
Hope to see you there!